Cargando…

WITHDRAWN: COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research

The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/10.1016/j.japh.2020.04.007. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/...

Descripción completa

Detalles Bibliográficos
Autores principales: Gormley, LCDR Andrea, Ngan, CDR Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the American Pharmacists Association. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146656/
http://dx.doi.org/10.1016/j.japh.2020.04.007
_version_ 1783520251603845120
author Gormley, LCDR Andrea
Ngan, CDR Kelly
author_facet Gormley, LCDR Andrea
Ngan, CDR Kelly
author_sort Gormley, LCDR Andrea
collection PubMed
description The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/10.1016/j.japh.2020.04.007. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal
format Online
Article
Text
id pubmed-7146656
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc. on behalf of the American Pharmacists Association.
record_format MEDLINE/PubMed
spelling pubmed-71466562020-04-10 WITHDRAWN: COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research Gormley, LCDR Andrea Ngan, CDR Kelly J Am Pharm Assoc (2003) Article The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/10.1016/j.japh.2020.04.007. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal Published by Elsevier Inc. on behalf of the American Pharmacists Association. 2020-04-10 /pmc/articles/PMC7146656/ http://dx.doi.org/10.1016/j.japh.2020.04.007 Text en © 2020 Published by Elsevier Inc. on behalf of the American Pharmacists Association. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gormley, LCDR Andrea
Ngan, CDR Kelly
WITHDRAWN: COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research
title WITHDRAWN: COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research
title_full WITHDRAWN: COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research
title_fullStr WITHDRAWN: COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research
title_full_unstemmed WITHDRAWN: COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research
title_short WITHDRAWN: COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research
title_sort withdrawn: covid-19 emergency responders in fda’s center for drug evaluation and research
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146656/
http://dx.doi.org/10.1016/j.japh.2020.04.007
work_keys_str_mv AT gormleylcdrandrea withdrawncovid19emergencyrespondersinfdascenterfordrugevaluationandresearch
AT ngancdrkelly withdrawncovid19emergencyrespondersinfdascenterfordrugevaluationandresearch